Market Tracker

09/29 9:39am ET
31.26
BATS BZX Real-Time Price
As of 9:37am ET
 -0.15 / -0.48%
Today’s Change
20.07
Today|||52-Week Range
36.00
+10.50%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close31.41
Today’s open31.26
Day’s range31.26 - 31.26
Volume14
Average volume (3 months)282,001
Market cap$1.1B
Dividend yield--
Data as of 9:37am ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+57.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio130.9
Price/Sales11.37
Price/Book8.43

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc0.000.00%
LCILannett Company Inc-0.15-0.53%
EGRXEagle Pharmaceutical...0.000.00%
SGYPSynergy Pharmaceutic...-0.15-2.58%
Data as of 9:39am ET, 09/29/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts